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Abstract
Autophagy, a homeostatic process involved in nutrient regeneration and immune responses, may be involved in 
intracellular killing of M. tuberculosis. Several studies linked variation in autophagy genes with susceptibility to 
pulmonary tuberculosis, but others did not confirm these findings.
We genotyped single nucleotide polymorphisms (SNPs) in the ATG5 (rs2245214, c.574-12777G>C) and NOD2 
(rs2066844, c.2104C>T) genes for 256 pulmonary tuberculosis patients and 330 unrelated healthy controls in 
Romania. Both SNPs have been reported as relevant for the autophagy process and potentially for susceptibility to 
active pulmonary tuberculosis. 
In our study, the polymorphisms in ATG5 and NOD2 were not associated with tuberculosis. This suggests that the 
two genetic variants we focused on are not related to the risk for developing active TB in a Romanian population.
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Rezumat
Autofagia, un proces homeostatic implicat în regenerarea nutrienților și a răspunsului imun, poate fi implicată în 
distrugerea intracelulară a M. tuberculosis. Unele studii au făcut legătura dintre unele variații în genele autofagiei 
și susceptibilitatea la tuberculoză, în timp ce alte studii nu confirmă acest lucru.
Am genotipat polimorfisme mononucleotidice (SNP) pentru genele ATG5 (rs2245214, c.574-12777G>C) și NOD2 
(rs2066844, c.2104C>T) pentru 256 pacienți cu tuberculoză pulmonară și 330 subiecți sănătoși neînrudiți, în Ro-
mânia. Ambele polimorfisme au fost raportate ca având relevanță pentru procesul de autofagie și potențial pentru 
susceptbilitatea pentru tuberculoză pulmonară activă.
În studiul nostru, polimorfismele genelor ATG5 și NOD2 nu au fost asociate cu tuberculoza. Acest fapt sugerează 
că cele două variante genetice pe care ne-am axat nu sunt legate de riscul de a dezvolta TB activă într-o populație 
românească.
Cuvinte cheie: tuberculoza, polimorfism, autofagie, sistem imun înnăscut, alele.
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Introduction
Pulmonary tuberculosis (TB), caused by infec-
tion with the bacillus Mycobacterium tubercu-
losis (Mtb), is the leading cause of death from 
infectious disease worldwide. World Health 
Organization reported more than 9.6 million new 
TB cases for 2014 and 1.5 million patients died 
due to this severe infection the same year. Mtb is 
transmitted between individuals mainly by aer-
osol droplets generated by patients with active 
pulmonary disease and is able to invade, persist 
and replicate inside macrophages by arresting 
phagosome maturation and inhibiting phago-
some-lysosome fusion. Macrophages can control 
this evasion by inducing autophagy, an elaborate 
cellular process through which cytoplasmic con-
tents that also include the bacilli, are targeted for 
lysososmal degradation, thus decreasing the bac-
terial burden within infected cells.
Autophagy is conserved during evolution, 
mediating the degradation of deficient organelles 
or proteins during stress or starvation conditions, 
allowing the eukaryotic cell to generate the nec-
essary nutrients. It has been revealed that auto-
phagy also modulates inflammation within the 
innate immune system, as well as adaptive im-
mune responses. Autophagy works by forming 
a double membrane structure called autophago-
some which sequestrates cytosolic material and 
later merges with the lysosome to degrade and 
afterwards release the resulted products back to 
the cytosol. This process is regulated by a spe-
cific set of genes from the autophagy-related 
family of genes (ATGs). Once the autophagy 
process is induced, different components of 
the autophagy pathway, such as ATG5, ATG12, 
ATG16 and LC3, cooperate to form the autopha-
gosomes and deliver the sequestrated material to 
the lysosome. ATG5 is a central regulator gene 
in the process of autophagy, being involved in 
the elongation of the autophagosome membrane. 
In addition, NOD2 (CARD15 or NLRC2) is an 
important member of the NLR family expressed 
in macrophages, granulocytes and monocytes, 
which recognizes both Gram-positive and Gram-
negative bacteria  and has been showed to con-
trol the autophagy process. A clear involvement 
of NOD2 in recognition of Mtb has been shown 
in NOD2-/- mice. On the other hand, the role of 
autophagy for anti-mycobacterial host defense 
has been challenged, by a recent study that while 
confirming that ATG5 has an important role in 
the host response to mycobacterial infection by 
restricting Mtb growth, it brought into question 
the role of autophagy in this process.
To investigate the role of autophagy for 
host defense against tuberculosis in humans, 
we hypothesized that genetic variants such as 
49Revista Română de Medicină de Laborator Vol. 25, Nr. 1, Ianuarie, 2017
the single nucleotide polymorphisms (SNPs) in 
the ATG5 - rs2245214 (c.574-12777G>C) and 
NOD2- rs2066844 (c.2104C>T) genes is associ-
ated with susceptibility to active TB. 
Material and Method
We genotyped ATG5 rs2245214 and NOD2 
rs2066844 SNPs in 256 unrelated Romanian 
patients with active or history of pulmonary 
TB (81.3% men, mean age 50.9 years) and in 
330 gender- and age- matched healthy unrelated 
Romanian subjects (57.3% men, mean age 60.7 
years) with no positive history of tuberculosis. 
Of note, the male to female ratio in the TB group 
is a common finding in epidemiological studies.
The subjects were enrolled during 2011-2013 
in Gorj and Dolj, South-Western Romania, two of 
the counties with high TB incidence in Romania. 
Active TB diagnosis was based on clinical, 
radiological and laboratory results (sputum mi-
croscopy and culture), according to National 
Standards as recommended by the National 
Programme for Tuberculosis Control. Sputum 
microscopy was performed with Ziehl-Neelsen 
staining, without prior concentration of the sam-
ple. Culturing was performed on Loewenstein 
Jensen solid media. Definite diagnosis was based 
on culture positivity. Clinical and pulmonary 
chest X-ray findings supported the diagnosis.
History of TB was mainly interview-based. 
Although hospital records were queried to con-
firm subject declared data, there are limitations 
to how extensive the databases are. Nonetheless, 
there were no discrepancies identified.
The control group was screened for active 
TB using a symptom screen and a pulmonary 
chest X-ray. Romania is in a highly endemic 
region, with possible high background latency. 
Latency testing is not routinely recommended 
by national guidelines in adults and has not been 
performed for the purposes of this study. 
Ethical approval for this study was obtained 
from the Ethics Committee of the University of 
Medicine and Pharmacy from Craiova, Romania, 
and all the tested subjects provided written in-
formed consent. 
Detection of the allelic variants was per-
formed on genomic DNA isolated and puri-
fied from peripheral venous blood samples 
collected on EDTA using TaqMan assays 
(C___3001905_20, C__11717468_20, Applied 
Biosystems, Foster City, CA) designed to detect 
the the rs2245214 and rs2066844 SNPs. The 
methodology and cycling protocol are similar to 
those used to detect other SNP allelic variants. 
Assessment of the Hardy-Weinberg equilib-
rium was performed with online software avail-
able at http://www.had2know.com/academics/
hardy-weinberg-equilibrium-calculator-2-al-
leles.html. Statistical analysis of the allelic vari-
ants and genotypes frequency was performed us-
ing GraphPad Prism, version 6.01 for Windows 
(GraphPad Software, La Jolla California, USA). 
Associations between genotypes and TB were 
calculated as odds ratios (OR) with 95% confi-
dence intervals, based on the dominant and re-
cessive models. 
Results and Discussion
ATG5 rs2245214 (c.574-12777G>C) and NOD2 
rs2066844 (c.2104C>T) genotype results for 
the TB and the control group are summarized in 
Table 1. To our knowledge, this is a first report 
of the single nucleotide polymorphisms (SNPs) 
in the Romanian population.
Frequency for the minor allele (G) for the in-
tronic rs2245214 was comparable between the TB 
group (33.01%) and the control group (33.38%). 
The reported frequency seems to be similar with 
the European population (AFR 53%, AMR 50%, 
ASN 47%, EUR 36%, based on the 1000 genomes 
study, using the HaploReg v4.1 online at http://
archive.broadinstitute.org/mammals/haploreg/
haploreg.php, accessed at 31/10/2016).
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Frequency for the minor allele (T) for the 
missense rs2066844 was 3.13% in the TB group 
and 3.64% in the control group, again com-
parable with European reported frequencies 
(AFR 0%, AMR 3%, ASN  0%, EUR 5%, using 
HaploReg v4.1).
Our findings did not reach significance for 
the two studied SNPs, ATG5 rs2245214 (c.574-
12777G>C) and NOD2 rs2066844 (c.2104C>T), 
under both the dominant and the recessive model 
of association between a genotype and a pheno-
type (see Table 1).
The frequencies of ATG5 rs2245214 (c.574-
12777G>C) and NOD2 rs2066844 (c.2104C>T) 
genotypic variants in patients diagnosed with ac-
tive TB or with known history of mycobacterial 
infection did not differ from those of the healthy 
individuals as seen above (Figure 1). The fre-
quencies of both genetic polymorphisms in the 
two groups were in Hardy-Weinberg equilibri-
um, and were not influenced by gender or age 
(Table 2). 
Autophagy was considered as a novel and 
promising pathway that can be used as a target 
for development of better vaccines and new 
drugs designed to eliminate Mtb, but recent 
studies have brought that hypothesis into ques-
tion (2). One particularly powerful approach to 
assess the role of certain processes for anti-tu-
berculosis host defence in humans is to investi-
gate whether genetic variation in genes involved 
in that pathway influence susceptibility to infec-
tion. Among the ATG family of genes, ATG5 is 
an important modulator of the autophagy pro-
cess charged with the expansion and closure of 
the double stranded structure called autophago-
Table 1. Genotype frequency for ATG5 rs2245214 (c.574-
12777G>C) and NOD2 rs2066844 (c.2104C>T)
ATG5 rs2245214 (c.574-12777G>C)
Genotype TB (%, n) Control (%, n)
CC 20.83%, 121 25.99%, 151
CG 17.83%, 101 22.55%, 131
GG 5.85%, 34 7.4%, 43
Dominant model
OR 0.9956, p = 0.9858
Recessive model
OR 1.0328, p = 0.8471
NOD2 rs2066844 (c.2104C>T)
Genotype TB (%, n) Control (%, n)
CC 40.96%, 240 52.39%, 307
CT 2.73%, 16 3.75%, 22
TT 0 0.17%, 1
Dominant model
OR 2.3354, p = 0.6040
Recessive model
OR 1.1238, p = 0.7289
Table 2. Hardy-Weinberg equilibrium for ATG5 rs2245214 (c.574-
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some. There are both in-vivo and in-vitro stud-
ies focused on autophagy and more specifically 
ATG5 gene and its involvement in tuberculosis. 
Different studies render different results for the 
in-vivo approach, thus there is either a modest 
deficiency in macrophage control following in-
fection in mouse strains which lack ATG5 in my-
eloid cells, or a severe one that leads to a higher 
level of bacteria and faster death. All these find-
ings point out that autophagy and ATG5 gene are 
essential for in vivo Mtb control. However, no 
clear conclusions regarding the role of genetic 
polymorphisms in ATG5 gene could be drawn, 
with some studies suggesting an impact on the 
susceptibility to TB, while not being able to re-
produce that. In the present study we aimed to 
investigate this hypothesis in a Romanian cohort 
with tuberculosis: no influence on susceptibility 
to infection could be observed.
Furthermore, little is known regarding sus-
ceptibility to tuberculosis in individuals carrying 
genetic variants in the NOD2 gene. The poten-
tial role played by the NOD2 gene in TB infec-
tion was suggested by two studies that revealed 
the involvement of this gene in recognition of 
Mtb through signalling the production of proin-
flamatory cytokines. Recent studies showed that 
NOD2 signaling can initiate the autophagy re-
sponse  sequestrating the intracellular bacteria in 
the autophagosome  and limiting the infection. 
NOD2 rs2066844 SNP was associated in mul-
tiple studies with susceptibility to other chronic 
pathological conditions such as Crohn’s disease, 
schizophrenia  and asthma. However, we were 
not able to identify any association between 
NOD2 rs2066844 (c.2104C>T) polymorphism 
and the increased risk to develop active TB. This 
observation, coupled with absence of effects of 
ATG5 genetic variants, suggest that autophagy 
and Mtb have a complex interaction, and that the 
autophagy process may be redundant for host 
defense against tuberculosis, as recently sug-
gested (2).
One limitation of the current study is repre-
sented by the size of the cohorts, which may not 
have been sufficient to exclude a role for ATG5 
and NOD2 in TB. In addition, our study was 
underpowered to assess the influence of ATG5 
and NOD2 genotypes on the severity of the dis-
ease. We acknowledge the possible bias the lack 
of latency status for the control group may in-
troduce. Though, progress from TB infection to 
clinically active case is complex and introducing 
latency into our model is debatable in improving 
the analysis of susceptibility to active pulmonary 
TB, especially given the sample size. 
In conclusion, this is the first study to assess 
the role of polymorphisms in autophagy genes in 
Figure 1. Frequency of ATG5 rs2245214 
(c.574- 12777G>C) polymorphism
Figure 2. Frequency of NOD2 rs2066844 
(c.2104C>T) polymorphism
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an Eastern-European population with a very high 
burden of tuberculosis, and these results suggest 
that the ATG5 and NOD2 genotypes are not re-
lated to the risk for developing active TB. In ad-
dition, we found no evidence of an interaction 
between ATG5 rs2245214 and NOD2 rs2066844 
variant genotypes.  The lack of association be-
tween ATG5 rs2245214 and NOD2 rs2066844 
and susceptibility to TB revealed by this study 
does not exclude the possibility that other SNPs 
in the two genes (or other autophagy genes) could 
contribute to the risk of developing active TB.
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